Top

Published in:

01-01-2006 | Editorial Commentary

Steroid elimination is coming of age

Author: Minnie Sarwal

Published in: Pediatric Nephrology | Issue 1/2006

Abstract

Steroid elimination is being achieved in organ transplantation. The newer generation of more powerful induction and maintenance immunosuppressants offer a new era of safe and effective steroid avoidance. The advantages of achieving independence from steroids definitely extend to the patient. Recent studies also suggest unexpected immunological benefits for the graft. Randomized studies of steroid avoidance and usage are warranted to confirm safety and efficacy, and to address pharmacokinetic and transcriptional changes as a result of steroid elimination, for optimum dosing and monitoring.

Cole E, Landsberg D, Russell D, Zaltzman J, Kiberd B, Caravaggio C, Vasquez AR, Halloran P (2001) A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 72:845–850PubMedCrossRef

Rostaing L, Cantarovich D, Mourad G, Budde K, Rigotti P, Mariat C, Margreiter R, Capdevilla L, Lang P, Vialtel P, Ortuno-Mirete J, Charpentier B, Legendre C, Sanchez-Plumed J, Oppenheimer F, Kessler M (2005) Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 79:807–814PubMedCrossRef

Boillot O, Mayer DA, Boudjema K, Salizzoni M, Gridelli B, Filipponi F, Trunecka P, Krawczyk M, Clavien PA, Ducerf C, Margarit C, Margreiter R, Pallardo JM, Hoeckerstedt K, Pageaux GP (2005) Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study. Liver Transplant 11:61–67CrossRef

Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr (2003) Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 76:1331–1339PubMedCrossRef

Sarwal MM, Yorgin PD, Alexander S, Millan MT, Belson A, Belanger N, Granucci L, Major C, Costaglio C, Sanchez J, Orlandi P, Salvatierra O Jr (2001) Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 72:13–21PubMedCrossRef

Boardman RE, Alloway RR, Alexander JW, Buell JF, Cardi M, First MR, Hanaway MJ, Munda R, Rogers CC, Roy-Chaudhury P, Susskind B, Trofe J, Woodle ES (2005) African–American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant 5:356–365PubMedCrossRef

Alloway RR, Hanaway MJ, Trofe J, Boardman R, Rogers CC, Buell JF, Munda R, Alexander JW, Thomas MJ, Roy-Chaudhury P, Cardi M, Woodle ES (2005) A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc 37:802–803PubMedCrossRef

Woodle ES, Vincenti F, Lorber MI, Gritsch HA, Hricik D, Washburn K, Matas AJ, Gallichio M, Neylan J (2005) A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. Am J Transplant 5:157–166PubMedCrossRef

Washburn K, Speeg KV, Esterl R, Cigarroa F, Pollack M, Tourtellot C, Maxwell P, Halff G (2001) Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil. Transplantation 72:1675–1679PubMedCrossRef

10.

Jordan ML, Chakrabarti P, Luke P, Shapiro R, Vivas CA, Scantlebury VP, Fung JJ, Starzl TE, Corry RJ (2000) Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. Transplantation 69:265–271PubMedCentralPubMedCrossRef

11.

Hocker B, John U, Plank C, Wuhl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tonshoff B (2004) Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Transplantation 78:228–234PubMedCrossRef

12.

Motoyama O, Hasegawa A, Ohara T, Satoh M, Shishido S, Honda M, Tsuzuki K, Kinukawa T, Hattori M, Ito K, Ogawa O, Yanagihara T, Saito K, Takahashi K, Ohshima S (2005) A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: results obtained between 1990 and 2003. Pediatr Transplant 9:232–238PubMedCrossRef

13.

Sarwal MM, Cecka JM, Millan MT, Salvatierra O Jr (2000) Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing. Transplantation 70:1728–1736PubMedCrossRef

14.

Vidhun JR, Sarwal MM (2005) Corticosteroid avoidance in pediatric renal transplantation. Pediatr Nephrol 20:418–426PubMedCrossRef

15.

Stratta RJ, Alloway RR, Hodge E, Lo A (2002) A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis. Clin Transplant 16:60–68PubMedCrossRef

16.

McCauley J (2005) Steroid-free lymphocyte depletion protocols. The potential for partial tolerance? Contrib Nephrol 146:43–53PubMed

17.

Satterwhite T, Chua MS, Hsieh SC, Chang S, Scandling J, Salvatierra O, Sarwal MM (2003) Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression. Pediatr Transplant 7:53–58PubMedCrossRef

18.

Matas AJ, Kandaswamy R, Humar A, Payne WD, Dunn DL, Najarian JS, Gruessner RW, Gillingham KJ, McHugh LE, Sutherland DE (2004) Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg 240:510–516; discussion 516–517PubMedCentralPubMedCrossRef

19.

Shapiro R, Basu A, Tan H, Gray E, Kahn A, Randhawa P, Murase N, Zeevi A, Girnita A, Metes D, Ness R, Bass DC, Demetris AJ, Fung JJ, Marcos A, Starzl TE (2005) Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg 200:505–515; quiz A559–A561PubMedCentralPubMedCrossRef

20.

Parrott NR, Hammad AQ, Watson CJ, Lodge JP, Andrews CD (2005) Multicenter, randomized study of the effectiveness of basiliximab in avoiding addition of steroids to cyclosporine a monotherapy in renal transplant recipients. Transplantation 79:344–348PubMedCrossRef

21.

Lim WK, Ursea R, Rao K, Buggage RR, Suhler EB, Dugan F, Chan CC, Straus SE, Nussenblatt RB (2005) Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome. Am J Ophthalmol 139:562–563PubMedCrossRef

22.

Kim JS, Aviles DH, Silverstein DM, Leblanc PL, Matti Vehaskari V (2005) Effect of age, ethnicity, and glucocorticoid use on tacrolimus pharmacokinetics in pediatric renal transplant patients. Pediatr Transplant 9:162–169PubMedCrossRef

23.

Vehaskari VM (1999) Treatment practices of FSGS among North American pediatric nephrologists. Pediatr Nephrol 13:301–303PubMedCrossRef

24.

Cattaneo D, Perico N, Gaspari F, Gotti E, Remuzzi G (2002) Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation. Kidney Int 62:1060–1067PubMedCrossRef

Title: Steroid elimination is coming of age
Author: Minnie Sarwal
Publication date: 01-01-2006
Publisher: Springer-Verlag
Published in: Pediatric Nephrology / Issue 1/2006
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-005-2042-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Steroid elimination is coming of age

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2006

Renal hypoplasia: lessons from Pax2

Factors affecting histological regression of crescentic Henoch–Schönlein nephritis in children

Stent-related ureteric obstruction in paediatric renal transplantation

Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells

Clinical course of prenatally detected primary vesicoureteral reflux

Report of an NIH task force on research priorities in chronic kidney disease in children